42351-98-4

Basic information

• Product Name: 2,4(1H,3H)-Pyrimidinedione, 6-methyl-, 4-hydrazone (9CI)
• Synonyms: 2,4(1H,3H)-Pyrimidinedione, 6-methyl-, 4-hydrazone (9CI)
• CAS NO: 42351-98-4
• Molecular Formula: C₅H₈N₄O
• Molecular Weight: 140.14322
• Product Categories: PYRIMIDINE
• Mol File: 42351-98-4.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2,4(1H,3H)-Pyrimidinedione, 6-methyl-, 4-hydrazone (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2,4(1H,3H)-Pyrimidinedione, 6-methyl-, 4-hydrazone (9CI)(42351-98-4)
• EPA Substance Registry System: 2,4(1H,3H)-Pyrimidinedione, 6-methyl-, 4-hydrazone (9CI)(42351-98-4)

Safety Data

• Hazardous Substances Data: 42351-98-4(Hazardous Substances Data)

Upstream product

• 16710-11-5 4-(methylthio)-6-methyluracil 
• 22727-18-0 4-chloro-2-ethylsulfanyl-6-methyl-pyrimidine 
• 626-48-2 6-Methyluracil 
• 638-13-1 6-methyl-4-sulfanylidene-1,2,3,4-tetrahydropyrimidin-2-one 

Downstream Products

• 106949-15-9 salicylaldehyde-(6-methyl-2-oxo-1,2-dihydro-pyrimidin-4-ylhydrazone) 
• 72411-36-0 2,7-dimethyl-s-triazolo<1,5-c>pyrimidin-5(6H)-one 
• 76044-35-4 7-methyl-2-phenyl-s-triazolo<1,5-c>pyrimidin-5(6H)-one 
• 56881-36-8 7-Methyl-s-triazolo<4.3-c>pyrimidin-5(6H)-on 
• 108669-79-0 7-methyl-3-phenyl-6H-[1,2,4]triazolo[4,3-c]pyrimidin-5-one 
• 76069-26-6 5-chloro-7-methyl-2-phenyl-s-triazolo<1,5-c>pyrimidine 
• 76044-67-2 5-methyl-8-phenylbis-s-triazolo<1,5-a:1',5'-c>pyrimidine 
• 76044-55-8 N-hydroxy-N'-(7-methyl-2-phenyl-s-triazolo<1,5-c>pyrimidin-5-yl)formamidine 
• 76044-50-3 N,N-dimethyl-N'-(7-methyl-2-phenyl-s-triazolo<1,5-c>pyrimidin-5-yl)formamidine 
• 76044-61-6 N-acetoxy-N'-(7-methyl-2-phenyl-s-triazolo<1,5-c>pyrimidin-5-yl)formamidine 
• 57369-88-7 3-{[(6-methyl-2-oxo-1(3),2-dihydro-pyrimidin-4-yl)-hydrazono]-methyl}-rifamycin 

Relevant articles and documents

SUBSTITUTED TRIAZOLO BICYCLICCOMPOUNDS AS PDE2 INHIBITORS

The present invention is directed to substituted triazolo bicycliccompounds of formula (I) which are useful as therapeutic agents for the treatment of central nervous system disorders associated with phosphodiesterase 2 (PDE2). The present invention also

Bis-s-triazolopyrimidine and Some Simple Derivatives

A general synthetic route to the new tricyclic system bis-s-triazolopyrimidine, is reported.Thus the parent heterocycle (11a) is prepared from the key bicyclic intermediate, s-triazolopyrimidin-5-ylamine (7a), through the correspondi